Iovance Biotherapeutics, Inc.
IOVANASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $6.34B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.76$15.30
- Volume (live)
- -
- Avg. volume (3M)
- 16.54M
Iovance Biotherapeutics (IOVA) Stock Price & Financial Analysis
Iovance Biotherapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $13.54 - $14.30 |
|---|---|
| 52-Week High | $15.30 |
| 52-Week Low | $1.76 |
| Open | $14.19 |
| Volume (last close) | 7.76M |
| Average Volume (3M) | 16.54M |
| Revenue (TTM) | 324.97M |
|---|---|
| Net Income (TTM) | -289.52M |
| Free Cash Flow (TTM) | -296.39M |
| EPS (TTM) | −$0.71 |
| Profit Margin | -89.09% |
| Operating Margin | -92.72% |
| Return on Equity (ROE) | -39.33% |
| Debt to Equity | 0.06 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 6.34B |
|---|---|
| Shares Outstanding | 450.19M |
| Price to Sales (P/S) | 19.52 |
| Price to Book (P/B) | 8.62 |
| EV/EBITDA | -23.69 |
| 50-Day MA | $10.45 |
|---|---|
| 200-Day MA | $5.42 |
| 1-Year Change | +545.66% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Iovance Biotherapeutics at a Glance
As of the Oct 23, 2026 close, Iovance Biotherapeutics (IOVA) has a market capitalization of $6.34B. The stock trades at 19.5× sales. Over the trailing twelve months it lost $289.52M on revenue of $324.97M and burned $296.39M of free cash flow. Revenue grew 34.5% year over year.
As of its latest reported balance sheet, it holds $110.77M in cash and securities against $46.00M of debt, a net cash position of $64.77M.
Iovance Biotherapeutics does not currently pay a dividend.
The share price is up 545.7% over the past year. At $14.09 (the Oct 23, 2026 close) it sits near the top of its 52-week range of $1.76 to $15.30, above its 200-day moving average of $5.42.
Based on 15 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $14.40, 2.2% above the Oct 23, 2026 close.
Frequently Asked Questions About Iovance Biotherapeutics
What is the current stock price for IOVA?
As of the Oct 23, 2026 close, IOVA stock trades at $14.09. The 52-week range is $1.76–$15.30, with a day range of $13.54–$14.30.
What is the P/E ratio for IOVA?
The P/E ratio (Price-to-Earnings) for IOVA is shown in the Key Statistics section. This valuation metric helps compare Iovance Biotherapeutics, Inc. to industry peers.
Does IOVA pay dividends?
Iovance Biotherapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for IOVA?
Based on ratings from 15 professional analysts over the last 90 days, the consensus for IOVA is Buy. The average 12-month price target is $14.40, a 2.2% upside from the Oct 23, 2026 close of $14.09.
What is the market cap of IOVA?
As of the Oct 23, 2026 close, Iovance Biotherapeutics's market capitalization is $6.34B, classifying it as a mid-cap company. Iovance Biotherapeutics operates in the Healthcare sector within the Biotechnology industry.